Table of Contents
<< Previous Issue | Jun 2021 (Vol: 2021, Issue: 6) | Next Issue >> |
- Section: Licensing
-
BMS Bolsters Pipeline with Two Billion-Dollar Deals
-
Genentech and Pieris Collaborate on Respiratory and Ophthalmology Therapies
-
Akebia Expands Renal Disease Portfolio with Cyclerion’s Praliciguat
- Section: Mergers & Acquisitions
-
MorphoSys Expands Oncology Footprint with Constellation and Royalty Pharma
- Section: Research & Development
-
Biogen Partners with Capsigen on AAV Capsids
-
MiNA Therapeutics Gains Another Partner in Lilly for its saRNA Technology
-
Amgen Continues to Grow Monoclonal Antibody Arsenal with Kirin’s KHK4083
-
Zai Lab Strengthens Oncology Pipeline with US$ 338 M Mirati Alliance in Greater China